0.3115
price down icon3.26%   -0.0105
 
loading
Carisma Therapeutics Inc stock is traded at $0.3115, with a volume of 357.43K. It is down -3.26% in the last 24 hours and down -23.07% over the past month. CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
See More
Previous Close:
$0.322
Open:
$0.3141
24h Volume:
357.43K
Relative Volume:
0.03
Market Cap:
$13.02M
Revenue:
$20.27M
Net Income/Loss:
$-63.80M
P/E Ratio:
-0.2049
EPS:
-1.52
Net Cash Flow:
$-68.35M
1W Performance:
-19.72%
1M Performance:
-23.07%
6M Performance:
-32.25%
1Y Performance:
-69.76%
1-Day Range:
Value
$0.2958
$0.322
1-Week Range:
Value
$0.2958
$0.3889
52-Week Range:
Value
$0.1417
$1.27

Carisma Therapeutics Inc Stock (CARM) Company Profile

Name
Name
Carisma Therapeutics Inc
Name
Phone
(267) 491-6422
Name
Address
3675 MARKET STREET, PHILADELPHIA
Name
Employee
46
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
CARM's Discussions on Twitter

Compare CARM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CARM
Carisma Therapeutics Inc
0.3115 13.46M 20.27M -63.80M -68.35M -1.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-12-24 Downgrade Robert W. Baird Outperform → Neutral
Dec-10-24 Downgrade BTIG Research Buy → Neutral
Apr-11-24 Initiated BTIG Research Buy
Oct-03-23 Initiated CapitalOne Overweight
Jul-06-23 Initiated Evercore ISI Outperform
May-31-23 Upgrade Jefferies Hold → Buy
May-24-23 Initiated H.C. Wainwright Buy
Apr-14-23 Initiated Robert W. Baird Outperform
View All

Carisma Therapeutics Inc Stock (CARM) Latest News

pulisher
Aug 01, 2025

Is it the right time to buy Carisma Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Is Carisma Therapeutics Inc. a growth stock or a value stockWealth Building Target Finder To Watch Now - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

How does Carisma Therapeutics Inc. compare to its industry peersFree Stock Target Finder That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What institutional investors are buying Carisma Therapeutics Inc. stockWealth Building Guidance For Smart Trading - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What is the dividend policy of Carisma Therapeutics Inc. stockBest Dividend Tracker For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 29, 2025

Carisma Therapeutics Inc. stock daily chart insightsMomentum Based Equity Trading Plans Reviewed - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Carisma Therapeutics Inc. stock outlook for YEARMarket Momentum and Signal Alerts Suggest Reversal - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Will Carisma Therapeutics Inc. Benefit From Sector TailwindsBuy Low Sell High Stock Watch Strategy in Focus - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Carisma Therapeutics Inc. stock price move sharplyValue Investing Picks With Stability Outlined - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Why Carisma Therapeutics Inc. stock attracts strong analyst attentionInvestment Strategy Designed for Capital Protection - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Moving Average Crossover Confirms Uptrend in Carisma Therapeutics Inc.Watchlist for Low Risk High Return Stocks Updated - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 21:04:54 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Applying big data sentiment scoring on Carisma Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Carisma Therapeutics Inc. stock outlook for YEAR Short-Term Profit Alert With Entry Forecast - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Does Carisma Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough gains with expert advice - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Carisma Therapeutics Inc. stock attracting strong analyst attentionRapidly growing investment returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Carisma Therapeutics Inc. (NASDAQ:CARM) Receives $1.93 Average Target Price from Brokerages - Defense World

Jul 28, 2025
pulisher
Jul 27, 2025

How volatile is Carisma Therapeutics Inc. stock compared to the marketInvest confidently with professional market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How many analysts rate Carisma Therapeutics Inc. as a “Buy”Capitalize on emerging growth stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Top Risks to Consider Before Buying Carisma Therapeutics Inc. StockHigh Return Investment Tips - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Has Carisma Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Popular Stock Recommendations - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Key External Factors That Drive Carisma Therapeutics Inc. Stock Price MovementsQuick Profit Idea Stream - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders - GlobeNewswire Inc.

Jul 26, 2025
pulisher
Jul 25, 2025

How high can Carisma Therapeutics Inc. stock price go in 2025Triple-digit returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Published on: 2025-07-25 09:50:28 - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Carisma Therapeutics Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Carisma Therapeutics Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 17:12:50 - jammulinksnews.com

Jul 22, 2025

Carisma Therapeutics Inc Stock (CARM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):